Mathias Toft

Mathias Toft

UNVERIFIED PROFILE

Are you Mathias Toft?   Register this Author

Register author
Mathias Toft

Mathias Toft

Publications by authors named "Mathias Toft"

Are you Mathias Toft?   Register this Author

72Publications

821Reads

18Profile Views

Missense mutations in DYT-TOR1A dystonia.

Neurol Genet 2019 Aug 6;5(4):e343. Epub 2019 Jun 6.

Department of Neurology (Z.I., L.P., S.P.H., C.C,. I.M.S,. M.T), Oslo University Hospital; Institute of Clinical Medicine (J.K., M.T), University of Oslo; Department of Neurology (J.K), Drammen Hospital, Vestre Viken Hospital Trust; Head and Neck Research Group, Research Center (M.B.R), Akershus University Hospital; Campus Akershus University Hospital (M.B.R), University of Oslo, Norway; and Faculty of Informatics, Laboratory for Bioinformatics, Modelling & Simulation of Biosystems (O.N.D.S), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563516PMC
August 2019

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Neurol Genet 2019 Aug 9;5(4):e348. Epub 2019 Jul 9.

Laboratory of Neurogenetics (H.I., C.B., H.L.L., F.F., D.G.H., A.B.S., M.A.N.), National Institute on Aging, National Institutes of Health, Bethesda; Data Tecnica International (H.I., M.A.N.), Glen Echo, MD; Precision Neurology Program (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Neurogenomics Laboratory (G.L., C.R.S.), Harvard Medical School, Brigham and Women's Hospital; Ann Romney Center for Neurologic Diseases (G.L., C.R.S.), Brigham and Women's Hospital, Boston, MA; The Norwegian Centre for Movement Disorders (J.M.-G., G.A.), Stavanger University Hospital; Department of Chemistry (J.M.-G., G.A.), Bioscience and Environmental Engineering, University of Stavanger, Norway; Assistance-Publique Hôpitaux de Paris (J.-C.C.), ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France; Department of Neurology (L.P., M.T.), Oslo University Hospital, Norway; Department of Neurology (M.N., B.R.B., B.P.W.), Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Michael J Fox Foundation (S.J.H.), New York; Translational Genome Sciences (K.-D.H.N, K.E.), Biogen, Cambridge, MA; Department of Neurology University of Pennsylvania (J.R.), Philadelphia, PA; Department of Biostatistics and Computational Biology (S.E.), University of Rochester, NY; Department of Computer Science (F.F.), University of Illinois Urbana-Champaign; Department of Neurology (P.A.), Center for Health + Technology, University of Rochester, NY; Department of Clinical Neurosciences (K.M.S., R.W.), University of Cambridge, John van Geest Centre for Brain Repair, UK; Department of Pathology and Laboratory Medicine (V.M.V.D.), Center for Neurodegenerative Disease Research, Parelman School of Medicine at the University of Pennsylvania, Philadelphia; Genetics and Pharmacogenomics (A.G.D.-W.), Merck Research Laboratory, Boston, MA; Statistical Genetics (A.G.D.-W.), Biogen, Cambridge, MA; Institut du cerveau et de la moelle épinière ICM (A.B., F.D.); Sorbonne Université SU (A.B.); INSERM UMR (A.B.), Paris, France; Department of Neurology (G.A.), Stavanger University Hospital, Norway; Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive Medicine, Queen Mary University of London; Department of Molecular Neuroscience (A.J.N.), UCL Institute of Neurology, London, UK; Department of Neurology (O.-B.T.), Haukeland University Hospital; University of Bergen (O.-B.T.), Bergen, Norway; Department of Neurology (J.R.E.), Nottingham University NHS Trust, UK; Centre for Clinical Brain Sciences (D.P.B.), University of Edinburgh; Anne Rowling Regenerative Neurology Clinic (D.P.B.), University of Edinburgh; Usher Institute of Population Health Sciences and Informatics (D.P.B.), University of Edinburgh, Scotland; Department of Medical and Molecular Genetics (C.E.W.), Indiana University, Indianapolis; Department of Neurology (D.K.S.), Beth Israel Deaconess Medical Center; Harvard Medical School (D.K.S.), Boston; Voyager Therapeutics (B.R.), Cambridge, MA; Department of Neurology (B.R.), University of Rochester School of Medicine, NY; Institute of Clinical Medicine (M.T.), University of Oslo, Norway; German Center for Neurodegenerative Diseases-Tubingen (P.H.); HIH Tuebingen (P.H.), Germany; Department of Psychiatry (D.W.), University of Pennsylvania School of Medicine; Department of Veterans Affairs (D.W.), Philadelphia, PA; and Department of Clinical Neurosciences (R.A.B., C.H.W.-G.), University of Cambridge, UK; Department of Neurology (J.J.V.H.), Leiden University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659137PMC
August 2019

Essential tremor.

Tidsskr Nor Laegeforen 2019 May 24;139(8). Epub 2019 Apr 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4045/tidsskr.18.0904DOI Listing
May 2019

TMEM230 variants in Parkinson's disease.

Nat Genet 2019 03;51(3):366

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41588-019-0353-7DOI Listing
March 2019

No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Neurobiol Aging 2019 02 22;74:236.e1-236.e5. Epub 2018 Sep 22.

Department of Neurology, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2018.09.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345552PMC
February 2019

The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.

Neurosci Lett 2017 Sep 19;658:48-52. Epub 2017 Aug 19.

Department of Neurology, Oslo University Hospital, Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2017.08.040DOI Listing
September 2017

Rare variants in dementia genes and Parkinson's disease.

Eur J Hum Genet 2016 12 22;24(12):1661-1662. Epub 2016 Jun 22.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2016.79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117929PMC
December 2016

Low frequency of GCH1 and TH mutations in Parkinson's disease.

Parkinsonism Relat Disord 2016 08 7;29:109-11. Epub 2016 May 7.

Department of Neurology, Oslo University Hospital, Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2016.05.010DOI Listing
August 2016

A cumulative genetic risk score predicts progression in Parkinson's disease.

Mov Disord 2016 Apr 8;31(4):487-90. Epub 2016 Feb 8.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26505DOI Listing
April 2016

Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?

JAMA Neurol 2016 Jan;73(1):21-2

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.3536DOI Listing
January 2016

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Alzheimers Dement 2015 Dec 30;11(12):1407-1416. Epub 2015 Apr 30.

Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2014.12.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627856PMC
December 2015

Cumulative genetic risk and age at onset in Parkinson's disease.

Mov Disord 2015 Oct 3;30(12):1712-3. Epub 2015 Aug 3.

Department of Neurology, Oslo University Hospital, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26366DOI Listing
October 2015

CHCHD2 and Parkinson's disease.

Lancet Neurol 2015 Jul;14(7):680-1

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(15)00096-4DOI Listing
July 2015

Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation.

Parkinsons Dis 2015 18;2015:461453. Epub 2015 Jun 18.

Department of Psychosomatic Medicine, Oslo University Hospital-Rikshospitalet, 0424 Oslo, Norway ; Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, 0424 Oslo, Norway ; Department of Neuropsychology, Helgeland Hospital, 8607 Mosjøen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/461453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488583PMC
July 2015

Parkinson's disease correlates with promoter methylation in the α-synuclein gene.

Mov Disord 2015 Apr 27;30(4):577-80. Epub 2014 Dec 27.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26073DOI Listing
April 2015

Personality changes after deep brain stimulation in Parkinson's disease.

Parkinsons Dis 2015 29;2015:490507. Epub 2015 Jan 29.

Department of Neuropsychiatry and Psychosomatic Medicine, Oslo University Hospital-Rikshospitalet, 0027 Oslo, Norway ; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/490507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325225PMC
February 2015

Clinical features associated with sleep disturbances in Parkinson's disease.

Clin Neurol Neurosurg 2014 Sep 27;124:37-43. Epub 2014 Jun 27.

Department of Neurology, Oslo University Hospital-Rikshospitalet, Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2014.06.027DOI Listing
September 2014

Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.

Ann Hum Genet 2014 May 24;78(3):243-52. Epub 2014 Mar 24.

Oslo University Hospital, Department of Neurology, P.O. Box 4950 Nydalen, 0424 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ahg.12060DOI Listing
May 2014

Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.

Mov Disord 2014 Feb 21;29(2):275-6. Epub 2013 May 21.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.25504DOI Listing
February 2014

REM sleep behavior disorder in Parkinson's disease--is there a gender difference?

Parkinsonism Relat Disord 2013 Jan 20;19(1):120-2. Epub 2012 Jun 20.

Department of Neurology, Drammen Hospital, Dronninggata 28, 3004 Drammen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2012.05.027DOI Listing
January 2013

The Wilson films--MS tremor.

Authors:
Mathias Toft

Mov Disord 2011 Dec;26(14):2471-2

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.24010DOI Listing
December 2011

Genetic variability in SNCA and Parkinson's disease.

Neurogenetics 2011 Nov 29;12(4):283-93. Epub 2011 Jul 29.

Department of Neurology, Oslo University Hospital, Rikshospitalet, P.O. Box 4950, Nydalen, 0424 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10048-011-0292-7DOI Listing
November 2011

Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.

Mov Disord 2011 Oct;26(12):2180-1

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23876DOI Listing
October 2011

Parkinson's disease: What remains of the "missing heritability"?

Mov Disord 2011 Sep 2;26(11):1971-3. Epub 2011 Aug 2.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23898DOI Listing
September 2011

Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.

Mov Disord 2011 Aug 8;26(10):1931-4. Epub 2011 Jun 8.

Department of Neurology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23817DOI Listing
August 2011

Aggravated stuttering following subthalamic deep brain stimulation in Parkinson's disease--two cases.

BMC Neurol 2011 Apr 8;11:44. Epub 2011 Apr 8.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2377-11-44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080297PMC
April 2011

International consortium identifies new genetic risk factors for Parkinson's disease.

Authors:
Mathias Toft

Mov Disord 2011 Mar;26(4):606

Department of Neurology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.23725DOI Listing
March 2011

Copy number variation in Parkinson's disease.

Genome Med 2010 Sep 6;2(9):62. Epub 2010 Sep 6.

Department of Neurology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien, 0027 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092113PMC
September 2010

[Treatment of movement disorders with deep brain stimulation].

Tidsskr Nor Laegeforen 2008 Sep;128(17):1972-6

Nevrologisk avdeling, Nevroklinikken, Rikshospitalet, 0027 Oslo.

View Article

Download full-text PDF

Source
September 2008

Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions.

Acta Neuropathol 2007 May 7;113(5):601-6. Epub 2006 Dec 7.

Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-006-0178-1DOI Listing
May 2007

MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease.

J Neurosci Res 2007 May;85(6):1288-94

Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jnr.21240DOI Listing
May 2007

Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway.

Neurosci Lett 2007 Apr 12;416(3):299-301. Epub 2007 Feb 12.

Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA, and Department of Neurology, St. Olav's Hospital, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2007.02.020DOI Listing
April 2007

ELAVL4, PARK10, and the Celts.

Mov Disord 2007 Mar;22(4):585-7

Department of Neuroscience and Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.21336DOI Listing
March 2007

Clinical heterogeneity of the LRRK2 G2019S mutation.

Arch Neurol 2006 Sep;63(9):1242-6

Department of Neurology, University of Miami School of Medicine, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.63.9.1242DOI Listing
September 2006

Lrrk2 and Lewy body disease.

Ann Neurol 2006 Feb;59(2):388-93

Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20731DOI Listing
February 2006

LRRK2 mutations are not common in Alzheimer's disease.

Mech Ageing Dev 2005 Nov;126(11):1201-5

Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mad.2005.06.010DOI Listing
November 2005

[Malignant hyperthermia--a hereditary and potentially life-threatening condition].

Tidsskr Nor Laegeforen 2005 Oct;125(20):2792-4

Department of Public Health, University of North Florida, USA.

View Article

Download full-text PDF

Source
October 2005

Clinical features of LRRK2-associated Parkinson's disease in central Norway.

Ann Neurol 2005 May;57(5):762-5

Department of Neurology, St. Olav's Hospital, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20456DOI Listing
May 2005

Parkinsonism, FXTAS, and FMR1 premutations.

Mov Disord 2005 Feb;20(2):230-3

Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.20297DOI Listing
February 2005

Premutation alleles and fragile X-associated tremor/ataxia syndrome.

JAMA 2005 Jan;293(3):296; author reply 296-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.293.3.296-aDOI Listing
January 2005

Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Am J Hum Genet 2004 Oct 3;75(4):669-77. Epub 2004 Aug 3.

Laboratories of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000292970762718
Publisher Site
http://dx.doi.org/10.1086/424492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1182054PMC
October 2004

[The genetics of Parkinson disease].

Tidsskr Nor Laegeforen 2004 Apr;124(7):922-4

Institutt for nevromedisin, Det medisinske fakultet, Norges teknisk-naturvitenskapelige universitet.

View Article

Download full-text PDF

Source
April 2004